Finance

Beta
Lists
ALMS:NASDAQ
Alumis Inc
$26.40
+5.47%
(+1.37) 1D
$25.88
-1.97% (-0.52)
After hours
Closed: Jun 26, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALMS...
Open
$25.01
High
$26.50
Low
$24.71
Mkt. cap
3.37B
Avg. vol.
1.18M
Volume
6.16M
52-wk high
$30.60
52-wk low
$2.92
EPS
-$1.92
Shares outstanding
123.43M
No. of employees
226
Open
$25.01
High
$26.50
Low
$24.71
Mkt. cap
3.37B
Avg. vol.
1.18M
Volume
6.16M
52-wk high
$30.60
52-wk low
$2.92
EPS
-$1.92
Shares outstanding
123.43M
No. of employees
226
News stories
From sources across the web
About Alumis Inc
CEO-
Employees226
Founded2021
HeadquartersSouth San Francisco, California, United States
SectorPharmaceutical industry
Websitealumis.com
Analyst ratings
Based on 8 analysts giving stock ratings to ALMS in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for ALMS in the last 3 months.
Highest
Current $26.40
$55.00 (+108.33%)
Average
$40.00 (+51.52%)
Lowest
$25.00 (-5.30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeff Jones
Oppenheimer
Buy
Reiterated
$55.00
+108.3%
06/26/2026
Janani Sundararajan
Chardan Capital
Buy
Reiterated
$40.00
+51.5%
05/19/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
$32.00
+21.2%
05/15/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
$39.00
+47.7%
05/15/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
$34.00
+28.8%
05/15/2026
Mitchell Kapoor
H.C. Wainwright
Hold
Downgraded
$25.00
-5.3%
05/15/2026
Derek Archila
Wells Fargo
Buy
Reiterated
$51.00
+93.2%
05/15/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
$44.00
+66.7%
04/04/2026
Christopher Raymond
Raymond James
Buy
Maintained
$46.00
+74.2%
03/27/2026
Last report
May 14, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.74 / -$0.83
+10.48%beat
Revenue / Est. (USD)
1.74M / 2.49M
-30.16%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.67M
2.07M
1.93M
1.74M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
102.06M
95.44M
83.48M
81.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.45M
17.62M
16.19M
18.61M
Operating expense
123.50M
113.06M
99.67M
100.15M
Total operating expenses
123.50M
113.06M
99.67M
100.15M
Operating income
-120.84M
-110.99M
-97.74M
-98.41M
Other non operating income
-38.00K
-54.00K
-33.00K
7.00K
EBT including unusual items
50.76M
-110.75M
-92.93M
-93.05M
EBT excluding unusual items
-117.45M
-106.45M
-94.23M
-93.05M
Income tax expense
-8.56M
-
-
-
Effective tax rate
-16.87%
-
-
-
Other operating expenses
-
-
-
-
Net income
59.32M
-110.75M
-92.93M
-93.05M
Net profit margin
2,225.09%
-5,360.70%
-4,817.57%
-5,344.80%
Earnings per share
-1.47
-1.06
-0.25
-0.74
Interest and investment income
3.43M
4.59M
3.55M
5.35M
Interest expense
-
-
-
-
Net interest expenses
3.43M
4.59M
3.55M
5.35M
Depreciation and amortization charges
-
-
-
-
EBITDA
-119.97M
-110.08M
-96.88M
-97.54M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of ALMS
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer